Pubblicazioni

Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsingÃ¢ÂÂremitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study)

2017 - JOURNAL OF NEUROLOGY

Comi, Giancarlo; Patti, Francesco; Rocca, Maria Assunta; Mattioli, Flavia Caterina; Amato, Maria Pia; Gallo, Paolo; Centonze, Diego; Pozzilli, Carlo; SaccÃ , Francesco; Bergh, Florian Then; Bartezaghi, Marta; Turrini, Renato; Filippi, Massimo; Patti, Francesco; Chisari, Clara Grazia; Marfia, Girolama Alessandra; Centonze, Diego; Morra, Vincenzo Brescia; Capra, Ruggero; Pozzilli, Carlo; Bianchi, Valentina; Ghezzi, Angelo; Roscio, Marco; Comi, Giancarlo; Sangalli, Francesca; Pietrolongo, Erika; Francia, Ada; Danni, Maura Chiara; Nocentini, Ugo; Bramanti, Placido; Tedeschi, Gioacchino; Maimone, Davide; Grimaldi, Luigi Maria Edoardo; Scarpini, Elio Angelo; Uccelli, Antonio; Amato, Maria Pia; Rottoli, Mariarosa; Ruggieri, Stefano; Trojano, Maria; Bergamaschi, Roberto; Bergh, Florian Then; Buttmann, Mathias; Rieckmann, Peter; Safavi, Ali

Pubblicazioni

Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsingÃ¢ÂÂremitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study)

Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsingÃ¢ÂÂremitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study)